Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Core / Intermediate Bond · Dunham

Dunham Dynamic Macro Fund Dunham Dynamic Macro Fund Class N (DNAVX)

Ticker DNAVX · · Holdings as of Jul 31, 2026

Expense ratio
1.5%$150/yr per $10k
5-yr return
+5.4%annualized
1-yr return
+5.1%as of Dec 2025
Net assets
$112.5Mall share classes
Holdings
46

Bottom line

Is DNAVX a good fund? The bottom line

DNAVX is a share class of Dunham Dynamic Macro Fund, a managed core / intermediate bond mutual fund from Dunham.

It charges 1.5% — about $150 a year on every $10,000 invested, more expensive than 88% of core / intermediate bond funds we track.

It returned +5.1% over one year, +5.4% a year over five years, +3.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $112 million in net assets and 46 holdings, its largest position is Morgan Stanley Institutional Liquidity Funds (8.4%) and the top 10 make up 45.3% of the portfolio.

What stands out

  • 5-year return beat 85% of category peers
  • No front-end sales load

What to watch

  • Expensive for its category (1.5%)
  • High turnover (145% a year) can mean more taxable distributions

Updated Nov 19, 2026

What DNAVX invests in

The Fund seeks to maximize total return from capital appreciation and dividends,

The Sub-Adviser?s macro asset allocation strategy is based primarily on the active management of the fund?s exposure to market risk in different asset classes and seeks to take advantage of opportunities arising from the variability of risk premia over time. The Fund?s Sub-Adviser seeks to achieve the total return component of the Fund?s investment objective by using a dynamic macro asset allocation strategy. The Fund may invest in or seek exposure to a wide range of asset classes including, without limitation, (i) equity (of any market capitalization), (ii) fixed-income (including all grades and maturities of domestic and foreign credit (including emerging markets) (iii) commodities, (iv) real estate investment trusts (?REITs?) and (v) currencies. The Sub-Adviser?s strategy seeks long and short exposure in these various asset classes and currencies. The Fund may take long positions…

From the fund's prospectus (filed Feb 27, 2026).

DNAVX performance

Fund calendar-year total returns, 2016–2025 2016: +2.3%; 2017: +8.1%; 2018: −8.5%; 2019: +14.0%; 2020: +1.6%; 2021: +9.3%; 2022: −14.0%; 2023: +18.7%; 2024: +10.9%; 2025: +5.1% +2% 2016 +8% 2017 −8% 2018 +14% 2019 +2% 2020 +9% 2021 −14% 2022 +19% 2023 +11% 2024 +5% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
DNAVX+5.1%+5.4%+3.8%
Core / Intermediate Bond median+7.2%+1.4%+3.0%

Source: Fund prospectus, as of Dec 31, 2025

Full DNAVX performance history →

What DNAVX costs

On a $10,000 investment, DNAVX's 1.5% expense ratio costs about $150 a year. The prospectus estimates $1,791 in total costs over 10 years (assuming 5% annual returns). The median core / intermediate bond fund charges 0.71%.

See the full DNAVX fee table →

DNAVX top 10 holdings

#Holding% of fund
1Morgan Stanley Institutional Liquidity Funds8.36%
2Spdr S&P 500 ETF Trust6.00%
3Invesco Exchange-traded Fund Trust II5.84%
4United States Of America - Bureau Of The Public Debt3.91%
5United States Of America - Bureau Of The Public Debt3.79%
6British Columbia (bc), Province Of - Ministry Of Finance And Corporate Relations3.57%
7Microsoft Corp3.54%
8United States Of America - Bureau Of The Public Debt3.49%
9United States Of America - Bureau Of The Public Debt3.39%
10United States Of America - Bureau Of The Public Debt3.39%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 45.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to DNAVX

More funds like DNAVX →

DNAVX FAQ

What is the expense ratio of DNAVX?
DNAVX's expense ratio is 1.5%, which works out to about $150 a year for every $10,000 invested. The prospectus estimates total costs of $1,791 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DNAVX a good investment?
It depends on your goals, but the data points to: 5-year return beat 85% of category peers; no front-end sales load; expensive for its category (1.5%); high turnover (145% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does DNAVX hold?
DNAVX's largest holdings are Morgan Stanley Institutional Liquidity Funds (8.4%), Spdr S&P 500 ETF Trust (6.0%), Invesco Exchange-traded Fund Trust II (5.8%), United States Of America - Bureau Of The Public Debt (3.9%), United States Of America - Bureau Of The Public Debt (3.8%). It holds 46 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is DNAVX's 5-year return?
DNAVX returned +5.4% a year over the five years ending Dec 31, 2025, and +3.8% a year over ten years. Past performance does not guarantee future results.
Does DNAVX have a sales load?
No. DNAVX has no front-end sales charge.
Who manages DNAVX?
DNAVX is offered by Dunham through Dunham Funds.